cardiology outline

7/28/2019 Cardiology Outline

1/6

Cardiology Outline

Cardiology Consist: Clinical Cardiology, Invasive & Non-invasive Cardiology, Cardiac Electrophysiology,

and Interventional Cardiology

General Training days

Tuesday 23 October 2012

General Day 1: Chest Pain & Stable Angina

Tuesday 11 December 2012

General Day 2: Acute coronary syndromes and myocardial infarction

Tuesday 22 January 2013

General Day 3: Cardiovascular response to exercise in health and disease; Cardiac rehabilitation

Monday 11 February 2013

General Day 4: Heart failure Day 2Friday 1 March 2013

General Day 5: Assessment and care of patients before and after cardiac and non-cardiac, surgery

Wednesday 17 April 2013

General Day 6: Heart Disease in Pregnancy

Thursday 20 June 2013

General Day 7: The prevention and management of endocarditis

Friday 5 July 2013

General Day 8: Pre-syncope, syncope and Bradyarrhythmias

Electrophysiology sub specialty training

Monday 3 December 2012

Day 1: Narrow complex tachycardia II

Monday 14th January 2013

Day 2: Cardiac arrhythmias and sudden death: From Bench to Bedside

Thursday 14 February 2013

Day 3: "Pacemaker implantation & programming, managing device-related complications Lead management,

engineering"

Friday 12 April 2013

Day 4: Narrow complex tachycardia III Tracings

Tuesday 14 May 2013

Day 5: Heart Failure and EP

Tuesday 4 June 2013

Day 6: Title to be confirmed


2/6

Wednesday 3 July 2013

Day 7: Atrial tachycardia

Cardiac imaging sub specialty training

Friday 12 October 2012

Cardiac Imaging Day 1

Wednesday 7 November 2012


Friday 8 February 2013


Friday 22 February 2013


Monday 25 March 2013

Cardiac Imaging Day 5/ BSE

Monday 29 April 29 2013


Thursday 27June 27 2013


Intervention sub specialty training

Friday 2 November 2012

Coronary artery assessment: Pressure and flow wire, IVUS, OCT

Wednesday 16 January 2013

Non-coronary intervention: Valves, septal ablation, PFO/ASD, carotid and renal interventions Tuesday 12

February 2013

Trial evaluation: design, statistics, interpretation

Wednesday 6 March 2013

PCI for STEMI/ACS: 2b3a, bival, PCI in NSEACS including timing

Friday 19 April 2013

Complications of PCI: Peri-and post-procedure, recognition and management

Thursday 6 June 2013

Complex PCI: CTOs, SVG, LM, bifurcations, calcified lesions

Heart failure sub specialty training

Friday 7 December 2012


3/6

Heart Failure Day 1

Friday 7 June 2013

Heart Failure Day 1

(also see General day 4 for Heart Failure Day 2)

Adult congenital heart disease

Monday 11 March 2013

ACHD Day1

Friday 27 September 2013

ACHD Day 2


4/6

Hypertension

Section 3: Genetics of Hypertension

I . Monogenic causes of human hypertension

A. Glucocorticoid remediable aldosteronism

B. Liddles syndrome

C. Apparent mineralocorticoid excess

D. Congenital adrenal hyperplasias

1. Caused by mutations in 11--hydroxylase

2. Caused by mutations in 17--hydroxylase

E. Pseudohypoaldosteronism Type II

F. Hypertension + brachydactyly syndrome

G. Gain of function mutation ofthe mineralocorticoid receptor

I I . Genetics of human primary hypertension

A. Risk of primary hypertension in population

B. Risk of primary hypertens ion in individuals with positive family history

C. Polygenic nature

D. Familial clustering of other cardiovascular risk factors

E. Renal involvement

F. Pharmacogenetic implications

Section 4: Pathophysiologic Mechanisms of Hypertension

I. Hemodynamic Subsets

II. Neural Mechanisms

III. Renal Mechanisms

IV. Vascular Mechanisms

V. Hormonal Mechanisms

A. Renin-Angiotensin-Aldosterone System


5/6

B. Endothelin

C. Insulin Resistance/Obesity

Section 5: Diagnostic Assessment

I . Accurate and adequate measurement of blood pressure (BP)

A. Office

B. Automatic ambulatory monitoring

C. Home, self- recorded

I I . Additional assessment of prognosis

A. Nocturnal pattern of BP

B. BP on arising

C. BP during exercise

D. Masked hypertension

I I I . White coat hypertension

IV. Initial evaluation

A. Purposes

1. Recognize specific identifiable causes of hypertension

2. Assess target organ damage

3. Determine overall cardiovascular risk status

B. Procedures

1. History

2. Physical examination, including fundoscopic

3. Laboratory testing: routine and additional as indicated

V. Overall cardiovascular risk stratification

Section 6: Metabolic Abnormalities and Hypertension

I . Obesity related hypertension

A. Prevalence of the association


6/6

B. Pathophysiology

C. Evaluation

D. Management

I I . Dyslipidemia

A. Prevalence of the association

B. Mechanisms

C. Management

I I I . The metabolic syndrome

A. Components of the syndrome

B. Pathophysiology

C. Management

IV. Diabetes mellitus

A. Prevalence of the association with types 1 and 2 diabetes

B. Pathophysiology

C. Evaluation

D. Management

cardiology outline

Documents